Caitong International Asset Management’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
RCM
ACA
JT
Caitong International Asset Management's ASND Position: Q2 2026 in Review
Caitong International Asset Management opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 158 shares worth $42.1K. The stake represents 0.01% of the portfolio and ranks #761 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in ASND as recently as Q4 2025.
Caitong International Asset Management first reported a position in ASND in Q4 2024 and has held it in 5 quarters since. The position peaked at $44.3K in Q1 2025. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.
- Caitong International Asset Management held 158 shares of Ascendis Pharma A/S worth $42.1K as of Q2 2026.
- Ascendis Pharma A/S was a new Caitong International Asset Management position in Q2 2026.
- Ascendis Pharma A/S made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #761 holding.
- Caitong International Asset Management first reported a position in Ascendis Pharma A/S in Q4 2024 and has held it in 5 quarters since.
- Caitong International Asset Management's Ascendis Pharma A/S position peaked at $44.3K in Q1 2025.
- 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.
Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.